Drug Trial Radar · NCT00006206
COMBINE (Acamprosate/Naltrexone)
Last checked: Nov 19, 2026Latest source record: May 3, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,375
Actual
Start
Aug 1997
Primary completion
Not stated
Study completion May 2006
Sponsor
- Lead sponsor
- University of North Carolina, Chapel HillAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Alcohol Abuse and Alcoholism (NIAAA); Lipha Pharmaceuticals
- First posted
- Sep 12, 2000
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Combine is a multicenter, randomized clinical trial that will evaluate combinations of three interventions for treating alcohol dependence. The goal is to determine whether improvement in treatment outcomes can be achieved by various combinations of drug and behavioral interventions. Two of the interventions will consist of pharmacological treatment with naltrexone (Revia) or acamprosate (Campral). The third intervention is a multicomponent behavioral therapy including such components as motivational enhancement therapy, cognitive behavioral therapy, and referral to self-help groups, including AA. All three interventions will include a component supporting compliance to medications and reduction in drinking.
Conditions
- Alcoholism
Interventions
naltrexone (Revia)Drug
acamprosate (Campral)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent days abstinent
- Time to relapse to heavy drinking
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Substance Abuse Treatment Unit, Yale University
New Haven, Connecticut
University of Miami School of Medicine
Miami, Florida
Harvard University/McLean Hospital
Belmont, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts
Boston University School of Medicine
Boston, Massachusetts
Center on Alcoholism, Substance Abuse and Addiction, University of New Mexico
Albuquerque, New Mexico
Treatment and Research Center, University of Pennsylvania
Philadelphia, Pennsylvania
Roger Williams Medical Center , Brown University
Providence, Rhode Island
Center for Alcohol Programs, Medical University of South Carolina
Charleston, South Carolina
Southwest Texas Addiction Research and Technology Center, University of Texas Health Science Center
San Antonio, Texas
Addictions Treatment Center, University of Washington
Seattle, Washington
University of Wisconsin-Milwaukee
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.